Active Surveillance for Localized Renal Masses: Tumor Growth, Delayed Intervention Rates, and >5-yr Clinical Outcomes.

[1]  B. Trock,et al.  Growth Kinetics of Small Renal Masses on Active Surveillance: Variability and Results from the DISSRM Registry , 2017, The Journal of urology.

[2]  Jeffrey A. Cadeddu,et al.  Adult Urology Oncology : Adrenal / Renal / Upper Tract / Bladder lized Renal Cancer : AUA Guideline , 2017 .

[3]  R. Uzzo,et al.  Active Surveillance for the Small Renal Mass: Growth Kinetics and Oncologic Outcomes. , 2017, The Urologic clinics of North America.

[4]  David C. Miller,et al.  Understanding Treatment Disconnect and Mortality Trends in Renal Cell Carcinoma Using Tumor Registry Data , 2017, Medical care.

[5]  David Gillatt,et al.  10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. , 2017, The New England journal of medicine.

[6]  A. Evans,et al.  Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  R. Uzzo,et al.  Active Surveillance for Small Renal Masses: When Less is More. , 2016, European urology focus.

[8]  J. Elmore.  Solving the Problem of Overdiagnosis. , 2016, The New England journal of medicine.

[9]  E. Bass,et al.  Management of Renal Masses and Localized Renal Cancer: Systematic Review and Meta-Analysis. , 2016, The Journal of urology.

[10]  T. Hoffmann,et al.  Patients' expectations of the benefits and harms of treatments, screening, and tests: a systematic review. , 2015, JAMA internal medicine.

[11]  A. Meraney,et al.  Active surveillance of renal masses: an analysis of growth kinetics and clinical outcomes stratified by radiological characteristics at diagnosis. , 2014, International braz j urol : official journal of the Brazilian Society of Urology.

[12]  Sudhir Srivastava,et al.  Addressing overdiagnosis and overtreatment in cancer: a prescription for change. , 2014, The Lancet. Oncology.

[13]  A. Evans,et al.  Growth kinetics of small renal masses: A prospective analysis from the Renal Cell Carcinoma Consortium of Canada. , 2014, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[14]  R. Uzzo,et al.  Small renal masses progressing to metastases under active surveillance , 2012, Cancer.

[15]  A. Evans,et al.  Active surveillance of small renal masses: progression patterns of early stage kidney cancer. , 2011, European urology.

[16]  Lorenzo Marconi,et al.  EAU guidelines on renal cell carcinoma: 2014 update. , 2010, European urology.

[17]  K. Badani,et al.  Active surveillance for renal cortical neoplasms. , 2010, The Journal of urology.

[18]  R. Uzzo,et al.  Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  S. Boorjian,et al.  Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance , 2009, Cancer.

[20]  B. Lane,et al.  Active surveillance of renal masses in elderly patients. , 2008, The Journal of urology.

[21]  W. Kassouf,et al.  Active surveillance for selected patients with renal masses , 2007, Cancer.

[22]  P. Ramchandani,et al.  Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging. , 2006, Urology.

[23]  Stephanie Daignault,et al.  Rising Incidence of Small Renal Masses: A Need to Reassess Treatment Effect , 2006 .

[24]  A. Hanlon,et al.  The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. , 2006, The Journal of urology.

[25]  R. Figlin,et al.  Cystic renal cell carcinoma: biology and clinical behavior. , 2004, Urologic oncology.

[26]  J. Cheville,et al.  An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. , 2002, The Journal of urology.

[27]  A. Jemal,et al.  Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[28]  R. Uzzo,et al.  Histopathological characteristics of localized renal cell carcinoma correlate with tumor size: a SEER analysis. , 2009, The Journal of urology.